Phase II study of rituximab (Rituxan, Mabthera) in Waldenstrom's macroglobulinaemia
Phase of Trial: Phase II
Latest Information Update: 30 Jul 2012
At a glance
- Drugs Rituximab (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 02 Mar 2010 Actual end date (Jul 2005) and actual number of patients (8) added as reported by ClinicalTrials.gov.
- 02 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.